LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated

levocetirizine dihydrochloride by

Drug Labeling and Warnings

levocetirizine dihydrochloride by is a Otc medication manufactured, distributed, or labeled by Chain Drug Marketing Association INC, Reed-Lane, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient (in each tablet)

Levocetirizine dihydrochloride USP, 5 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other respiratory allergies:

• runny nose
• sneezing
• itchy, watery eyes
• itching of the nose or throat

Warnings

Do not use

• if you have kidney disease
• if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

Ask a doctor before use if you have

• ever had trouble urinating or emptying your bladder

When using this product

• drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery 

Stop use and ask doctor if

• you have trouble urinating or emptying your bladder
• an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

• if breast-feding: not recommended
• if pregnant: ask a health professional before use

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

• adults 65 years of age and older:
  • ask a doctor
• adults and children 12-64 years of age:
  • take 1 tablet (5 mg) once daily in the evening
  • do not take more than 1 tablet (5 mg) in 24 hours
  • 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
• children 6-11 years of age:
  • take 1/2 tablet (2.5 mg) once daily in the evening
  • do not take more than 1/2 tablet (2.5 mg) in 24 hours
• children under 6 years of age:
  • do not use
• consumers with kidney disease:
  • do not use

Other information

• store between 20° and 25°C (68° and 77°F)
• (bottles only) safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
• (blister only) safety sealed: do not use if seal is broken or if individual blister unit is open or torn

Inactive ingredients

colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

Questions or comments?

Call 1-888-375-3784

Levocetirizine Dihydrochloride Tablets, USP 5 mg carton label

Original Prescription Strength

Levocetirizine
Dihydrochloride
Tablets USP, 5 mg
Antihistamine

ALLERGY

24 HOUR

Relief of:

• Sneezing
• Runny Nose
• Itchy Nose or Throat
• Itchy, Watery Eyes

35 Tablets

Levocetirizine Dihydrochloride Tablets USP, 5 mg bottle label

Original Prescription Strength
Levocetirizine
Dihydrochloride Tablets USP, 5 mg
Antihistamine

ALLERGY

24 HOUR

35 Tablets

INGREDIENTS AND APPEARANCE

LEVOCETIRIZINE DIHYDROCHLORIDE 
levocetirizine dihydrochloride tablet, coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 63868-473(NDC:43598-735)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
levocetirizine dihydrochloride (UNII: SOD6A38AGA) (levocetirizine - UNII:6U5EA9RT2O)	levocetirizine dihydrochloride	5 mg

Inactive Ingredients
Ingredient Name	Strength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYPROMELLOSES (UNII: 3NXW29V3WO)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A)

Product Characteristics
Color	white	Score	2 pieces
Shape	OVAL	Size	9mm
Flavor		Imprint Code	L
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 63868-473-35	1 in 1 CARTON	06/24/2020
1		35 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA210375	06/24/2020

Labeler - Chain Drug Marketing Association INC (011920774)

Establishment
Name	Address	ID/FEI	Business Operations
Reed-Lane, Inc.		001819879	repack(63868-473)